Skip to main content
. 2019 Oct 9;21(1):26–33. doi: 10.1080/15384047.2019.1665392

Figure 2.

Figure 2.

The prevalence of a targetable genotype in different age groups.

(a). The frequency of targetable genomic alterations in different age groups of patients with lung adenocarcinoma. (b). The correlation between the likelihood of harboring a targetable genotype and age was analyzed. Statistical significance was defined as P < .05.